FineMark National Bank & Trust’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-350
Closed -$39K 709
2016
Q4
$39K Hold
350
﹤0.01% 678
2016
Q3
$41K Sell
350
-17
-5% -$2K ﹤0.01% 656
2016
Q2
$41K Buy
367
+17
+5% +$1.83K ﹤0.01% 648
2016
Q1
$35K Sell
350
-350
-50% -$33.6K ﹤0.01% 667
2015
Q4
$74K Sell
700
-12
-2% -$1.24K 0.01% 501
2015
Q3
$67K Sell
712
-10
-1% -$1.03K 0.01% 547
2015
Q2
$75K Buy
722
+72
+11% +$7.5K 0.01% 549
2015
Q1
$70K Buy
650
+9
+1% +$926 0.01% 576
2014
Q4
$60K Buy
641
+349
+120% +$30.8K 0.01% 607
2014
Q3
$25K Hold
292
﹤0.01% 833
2014
Q2
$25K Buy
292
+233
+395% +$20.2K ﹤0.01% 844
2014
Q1
$5K Sell
59
-60
-50% -$4.79K ﹤0.01% 1167
2013
Q4
$10K Sell
119
-281
-70% -$24K ﹤0.01% 1018
2013
Q3
$34K Buy
400
+200
+100% +$16.8K 0.01% 656
2013
Q2
$17K Buy
+200
New +$16.6K 0.01% 840

Other funds holding LH

FineMark National Bank & Trust's LH Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Labcorp (LH) in Q1 2017, closing a stake of 350 shares — an estimated $39K sold.

FineMark National Bank & Trust first reported a position in LH in Q2 2013 and held it in 15 quarters. The position peaked at $75K in Q2 2015. 693 funds tracked by Wall St. Rank hold LH as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining Labcorp position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 350 Labcorp shares in Q1 2017, an estimated $39K.
  • FineMark National Bank & Trust first reported a position in Labcorp in Q2 2013 and held it in 15 quarters.
  • FineMark National Bank & Trust's Labcorp position peaked at $75K in Q2 2015.
  • 693 funds tracked by Wall St. Rank held Labcorp as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.